Cdkn1A Polyclonal Antibody

The Cdkn1A Polyclonal Antibody is applicable for the following applications: ELISA, IHC, IF. Host: Rabbit. Species Reactivity: Human (Homo sapiens) . Immunogen: Recombinant Human Cyclin-Dependent Kinase Inhibitor 1 Protein (2-164Aa) . Accession Number: P38936. Target Synonyms: CAP20; CDK-interacting protein 1; CDKI; CDKN1; Cdkn1a; CDN1A_HUMAN; CIP1; Cyclin Dependent Kinase Inhibitor 1A; Cyclin-dependent kinase inhibitor 1; Cyclin-dependent kinase inhibitor 1A (P21) ; Cyclin-dependent kinase inhibitor 1A (p21; Cip1) ; DNA Synthesis Inhibitor; MDA-6; MDA6; Melanoma differentiation-associated protein 6; Melanoma differentiation-associated protein; p21; P21 protein; p21CIP1; p21Cip1/Waf1; p21WAF; PIC1; SDI1; SLC12A9; WAF1; Wild type p53 activated fragment 1 (WAF1) ; Wild type p53 activated fragment 1; Wildtype p53-activated fragment 1. Restrictions: For Research Use Only. Not for use in diagnostic procedures.

Product Specifications

CAS Number

9007-83-4

Short Description

The Cdkn1A Polyclonal Antibody is applicable for the following applications: ELISA, IHC, IF.

Accession Number

P38936

Host

Rabbit

Reactivity

Human (Homo sapiens)

Immunogen

Recombinant Human Cyclin-Dependent Kinase Inhibitor 1 Protein (2-164Aa)

Target

CDKN1A

Clonality

Polyclonal

Conjugation

Unconjugated. Conjugated antibodies are available (Biotin, FITC and HRP), please inquire.

Applications

ELISA, IHC, IF

Field of Research

Cell Biology

Purification

>95%, Protein G Purified

Concentration

Lot specific. Please inquire or refer to the datasheet included in the product pouch.

Buffer

Preservative: 0.03% Proclin 300, Constituents: 50% Glycerol, 0.01M PBS, PH 7.4

Shipping Conditions

Ice packs

Storage Conditions

2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.

Appearance

Liquid

Fragment

IgG

Target Alternative Name

CAP20; CDK-interacting protein 1; CDKI; CDKN1; Cdkn1a; CDN1A_HUMAN; CIP1; Cyclin Dependent Kinase Inhibitor 1A; Cyclin-dependent kinase inhibitor 1; Cyclin-dependent kinase inhibitor 1A (P21) ; Cyclin-dependent kinase inhibitor 1A (p21; Cip1) ; DNA Synthesis Inhibitor; MDA-6; MDA6; Melanoma differentiation-associated protein 6; Melanoma differentiation-associated protein; p21; P21 protein; p21CIP1; p21Cip1/Waf1; p21WAF; PIC1; SDI1; SLC12A9; WAF1; Wild type p53 activated fragment 1 (WAF1) ; Wild type p53 activated fragment 1; Wildtype p53-activated fragment 1